Relatório de Análise de Tamanho, Participação e Tendências do Mercado Europeu de Diagnóstico Multiplex Sindrômico – Visão Geral e Previsão do Setor até 2032

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Medical Devices Europe Syndromic Multiplex Diagnostic Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Relatório de amostra grátis Relatório de amostra grátis Consulte antes Comprar Consulte antes Comprar agora Comprar agora

Relatório de Análise de Tamanho, Participação e Tendências do Mercado Europeu de Diagnóstico Multiplex Sindrômico – Visão Geral e Previsão do Setor até 2032

  • Medical Devices
  • Publish Reports
  • Apr 2025
  • Europe
  • 350 Páginas
  • Número de tabelas: 448
  • Número de figuras: 41
Comprar agora Comprar agora Descarregue amostra grátis de PDF Descarregue amostra grátis de PDF
Nucleus Nucleus

Contorne os desafios das tarifas com uma consultoria ágil da cadeia de abastecimento

A análise do ecossistema da cadeia de abastecimento agora faz parte dos relatórios da DBMR

Europe Syndromic Multiplex Diagnostic Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Chart Image USD 1.17 Billion USD 2.19 Billion 2024 2032
Diagram Período de previsão
 2025 –2032
Diagram Tamanho do mercado (ano base )
 USD 1.17 Billion
Diagram Tamanho do mercado ( Ano de previsão)
 USD 2.19 Billion
Diagram CAGR
 %
Diagram Principais participantes do mercado
  • F. Hoffmann-La Roche Ltd
  • DiaSorin S.p.A
  • BIOMÉRIEUX
  • Thermo Fisher Scientific Inc.
  • QIAGEN

Segmentação do mercado de diagnóstico multiplex sindrômico na Europa, por tipo de produto (acessórios e consumíveis, instrumentos e software e serviços), tipo de infecção (viral, bacteriana, fúngica, parasitária e outras), doença (infecções respiratórias, gastroenterite, infecções sexualmente transmissíveis , meningite, infecções infantis, imunossupressão, febre tropical, hepatite, infecções oculares e outras doenças), usuário final (hospitais, laboratórios clínicos, consultórios médicos, empresas farmacêuticas e de biotecnologia, institutos de pesquisa e outros), canal de distribuição (licitação direta, vendas no varejo e outros) - Tendências do setor e previsão até 2032

Mercado de Diagnóstico Multiplex Sindrômico

Análise de Mercado de Diagnóstico Multiplex Sindrômico

O mercado de diagnóstico multiplex sindrômico está experimentando um crescimento significativo devido à crescente demanda por diagnósticos rápidos e precisos e ao aumento de doenças infecciosas. Essas plataformas de diagnóstico permitem a detecção simultânea de múltiplos patógenos, melhorando a eficiência e os resultados para os pacientes. Os principais impulsionadores incluem avanços em diagnósticos moleculares, investimentos governamentais em infraestrutura de saúde e a crescente conscientização sobre medicina personalizada. Além disso, a pandemia de COVID-19 acelerou a adoção de sistemas de diagnóstico multiplex. Os principais players do mercado estão se concentrando em inovações de produtos e expandindo sua presença regional, aumentando ainda mais a competitividade do mercado e contribuindo para o crescimento geral do setor de saúde na Europa.

Mercado de Diagnóstico Multiplex SindrômicoMercado de Diagnóstico Multiplex Sindrômico

Tamanho do mercado de diagnóstico multiplex sindrômico

Espera-se que o mercado europeu de diagnóstico multiplex sindrômico atinja US$ 2,19 bilhões até 2032, ante US$ 1,17 bilhão em 2024, crescendo a um CAGR de 8,2% no período previsto de 2025 a 2032. Além dos insights sobre cenários de mercado, como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e principais participantes, os relatórios de mercado selecionados pela Data Bridge Market Research também incluem análise de importação e exportação, visão geral da capacidade de produção, análise de consumo de produção, análise de tendência de preço, cenário de mudança climática, análise da cadeia de suprimentos, análise da cadeia de valor, visão geral de matéria-prima/consumíveis, critérios de seleção de fornecedores, análise PESTLE, análise de Porter e estrutura regulatória.

Tendências do mercado de diagnóstico multiplex sindrômico

“Aumento dos testes no local de atendimento em diagnósticos multiplex sindrômicos”

Os testes no local de atendimento (Point-of-Care Tests) são uma tendência significativa no mercado europeu de diagnóstico multiplex sindrômico. A crescente demanda por diagnósticos rápidos e no local está impulsionando a adoção de dispositivos de teste multiplex portáteis e fáceis de usar. Essas soluções no local de atendimento permitem a detecção mais rápida de múltiplos patógenos, melhorando os resultados dos pacientes ao permitir decisões de tratamento oportunas. Essa tendência é particularmente benéfica em cenários de emergência, áreas rurais e durante surtos, onde o diagnóstico rápido é crucial. Com os avanços na tecnologia de diagnóstico miniaturizado, esses dispositivos estão se tornando mais precisos, econômicos e fáceis de usar, expandindo significativamente seu papel na prestação de cuidados de saúde em toda a Europa.

Escopo do Relatório e Segmentação do Mercado de Diagnóstico Multiplex Sindrômico                   

Atributos

Principais insights de mercado sobre diagnóstico multiplex sindrômico

Segmentos abrangidos
  • Por tipo de produto: acessórios e consumíveis, instrumentos e software e serviços
  • Por tipo de infecção: viral, bacteriana, fúngica, parasitária e outras
  • Por doença: infecções respiratórias, gastroenterite, infecções sexualmente transmissíveis, meningite, infecções infantis, imunossupressão, febre tropical, hepatite, infecções oculares e outras doenças
  • Por usuário final: hospitais, laboratórios clínicos, consultórios médicos, empresas farmacêuticas e de biotecnologia, institutos de pesquisa e outros
  • Por canal de distribuição: licitação direta, vendas no varejo e outros

Países abrangidos

Alemanha, Reino Unido, França, Itália, Espanha, Rússia, Holanda, Suíça, Turquia, Bélgica, Suécia, Polônia, Dinamarca, Noruega, Finlândia e resto da Europa

Principais participantes do mercado

F. Hoffmann-La Roche Ltd (Suíça), DiaSorin SpA (Itália), BIOMÉRIEUX (França), Thermo Fisher Scientific Inc. (EUA), QIAGEN (Holanda), BD Veritor (BD) (EUA), Bio-Rad Laboratories, Inc. (EUA), Danaher Corporation (EUA), Seegene Inc. (Coreia do Sul), Hologic, Inc. (EUA), Bosch Healthcare Solutions GmbH (Alemanha), Abbott (EUA), QuidelOrtho Corporation (EUA), Biocartis (Bélgica) e PathoFinder (Holanda), entre outros

Oportunidades de mercado
  • Avanços em IA e automação
  • Aumento da população idosa na Europa

Conjuntos de informações de dados de valor agregado

Além dos insights sobre cenários de mercado, como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e principais participantes, os relatórios de mercado selecionados pela Data Bridge Market Research também incluem análises aprofundadas de especialistas, análises de importação/exportação, análises de preços, análises de consumo de produção e análises PESTLE.

Definição de Mercado de Diagnóstico Multiplex Sindrômico

O mercado europeu de diagnóstico multiplex sindrômico refere-se aos testes e plataformas de diagnóstico que detectam simultaneamente múltiplos patógenos ou biomarcadores em uma única amostra, permitindo o diagnóstico rápido de diversas doenças, incluindo doenças infecciosas, câncer e doenças genéticas. Esses diagnósticos permitem que os profissionais de saúde identifiquem rapidamente a causa dos sintomas de um paciente, melhorando os resultados do tratamento e reduzindo os custos da saúde. O mercado é impulsionado por avanços tecnológicos em diagnósticos moleculares, pela crescente demanda por testes mais rápidos e precisos e por um foco crescente na medicina personalizada.

Dinâmica do Mercado de Diagnóstico Multiplex Sindrômico

Motoristas

  • Aumento da prevalência de doenças infecciosas

A carga de doenças infecciosas está aumentando rapidamente em toda a Europa. Vários tipos de microrganismos patogênicos estão associados a doenças infecciosas, como vírus, fungos, bactérias e parasitas. À medida que as doenças infecciosas se tornam mais frequentes e complexas, a necessidade de ferramentas de diagnóstico mais eficientes, rápidas e abrangentes torna-se crítica. O diagnóstico multiplex sindrômico oferece uma solução, permitindo a detecção simultânea de múltiplos patógenos em um único teste, uma capacidade que está se tornando cada vez mais essencial diante de doenças infecciosas novas e reemergentes. O aumento de casos de doenças infecciosas está aumentando a taxa de diagnóstico multiplex sindrômico, o que impulsiona o crescimento do mercado.

Por exemplo,

Em dezembro de 2023, a OMS relatou que as infecções respiratórias sazonais estavam aumentando em toda a Região Europeia da OMS, com VSR, COVID-19, gripe e Mycoplasma pneumoniae causando aumento nas hospitalizações. Crianças pequenas, idosos e indivíduos com doenças subjacentes enfrentam riscos maiores. O fortalecimento das medidas preventivas, incluindo vacinação e práticas de higiene, continua sendo crucial para mitigar a doença e reduzir a sobrecarga do sistema de saúde.

A crescente prevalência de doenças infecciosas em toda a Europa impulsiona a demanda por soluções avançadas de diagnóstico. O diagnóstico multiplex sindrômico, com sua capacidade de detectar múltiplos patógenos em um único teste, atende à crescente necessidade de identificação rápida e precisa de doenças. Essa tendência impulsiona significativamente o crescimento do mercado.

  • Adoção crescente de técnicas de diagnóstico molecular

O diagnóstico molecular é uma área em rápida evolução e transformação que está revolucionando a detecção, o tratamento e a pesquisa de doenças. Ele permite a identificação precisa de doenças infecciosas, muitas vezes em estágio inicial. No diagnóstico molecular, ensaios de painel de PCR multiplex (Reação em Cadeia da Polimerase) são utilizados para diagnosticar doenças infecciosas, detectando simultaneamente material genético de vários patógenos. Esses ensaios podem identificar diferentes tipos de microrganismos, incluindo fungos, parasitas, bactérias e vírus, em vários níveis taxonômicos.

Com a crescente dependência de técnicas de diagnóstico molecular, a detecção de patógenos tornou-se mais abrangente e eficiente. A PCR multiplex e as tecnologias avançadas de sequenciamento desempenham um papel crucial para permitir o diagnóstico rápido e preciso de doenças, melhorando, em última análise, os resultados dos pacientes. A crescente demanda por soluções de saúde precisas e oportunas está impulsionando a inovação no mercado, levando a uma melhor tomada de decisões clínicas e a estratégias de tratamento mais eficazes.

Por exemplo,

Em março de 2024, de acordo com um artigo publicado pela Elsevier Inc., a crescente adoção de técnicas de diagnóstico molecular, especialmente métodos baseados em PCR, transformou significativamente a forma como as doenças infecciosas são diagnosticadas. Os painéis multiplex de PCR aprovados pela FDA agora são capazes de detectar patógenos responsáveis ​​por infecções respiratórias com alta sensibilidade e resultados rápidos. Esses painéis não apenas permitem diagnósticos oportunos e precisos, mas também ajudam a orientar as decisões de tratamento antimicrobiano, melhorando, em última análise, os resultados clínicos e otimizando o atendimento ao paciente.

O uso crescente de diagnósticos moleculares e técnicas multiplex sindrômicas está remodelando a área da saúde, fornecendo resultados rápidos e precisos para diversas infecções. Essas inovações agilizam o diagnóstico, reduzem custos e aumentam a precisão do tratamento, tornando-as ferramentas essenciais para o tratamento de doenças complexas e a melhoria do atendimento a pacientes em todo o mundo.

Mercado de Diagnóstico Multiplex Sindrômico

Oportunidades

  • Avanços em IA e Automação

Avanços em IA e automação estão transformando o mercado europeu de diagnóstico multiplex sindrômico, aprimorando a precisão, a eficiência e a velocidade dos processos. Algoritmos baseados em IA estão sendo integrados a plataformas de diagnóstico sindrômico para analisar conjuntos de dados complexos, identificar patógenos com mais precisão e reduzir a probabilidade de falsos positivos ou negativos. Modelos de aprendizado de máquina estão agilizando a interpretação de resultados, permitindo tomadas de decisão clínicas mais rápidas e minimizando erros humanos. A automação otimiza ainda mais o manuseio, o processamento e a geração de resultados de amostras, reduzindo a dependência de pessoal qualificado e melhorando a eficiência geral do fluxo de trabalho do laboratório. A análise preditiva com tecnologia de IA também está auxiliando na detecção precoce de doenças e no monitoramento de surtos, permitindo que os profissionais de saúde tomem medidas proativas. A integração da automação com o diagnóstico multiplex sindrômico garante testes consistentes e de alto rendimento. Isso é especialmente benéfico para grandes instalações de saúde e centros de diagnóstico que lidam com altos volumes de pacientes. À medida que a IA continua a evoluir, seu papel no refinamento da precisão do diagnóstico sindrômico e na redução do tempo torna-se cada vez mais crítico.

Por exemplo,

Em dezembro de 2024, de acordo com um artigo do NCBI, os avanços futuros no diagnóstico multiplex sindrômico podem envolver a integração de painéis sindrômicos moleculares multiplex rápidos (RMMSP) com inteligência artificial preditiva, melhorando a precisão diagnóstica e otimizando o manejo de pacientes gravemente enfermos e infectados. A automação orientada por IA pode aprimorar a interpretação de resultados, reduzir erros humanos e otimizar fluxos de trabalho. A automação por IA e as inovações moleculares redefinirão os diagnósticos, aumentando a eficiência e a precisão, ao mesmo tempo em que aprimoram o atendimento ao paciente. Essa evolução abrirá novas possibilidades para o diagnóstico multiplex sindrômico, impulsionando avanços na detecção de doenças e nos resultados da saúde.

Algoritmos baseados em IA melhoram a detecção de patógenos, reduzem erros e aceleram decisões clínicas. A automação agiliza o processamento de amostras e minimiza a dependência de pessoal qualificado. Análises baseadas em IA auxiliam na detecção precoce de doenças, aumentando a capacidade diagnóstica. Esses avanços representam uma oportunidade significativa, pois aumentam a eficiência e a acessibilidade, promovendo a expansão do mercado.

  • Aumento da população idosa na Europa

À medida que as pessoas envelhecem, seus sistemas imunológicos enfraquecem, tornando-as mais suscetíveis a infecções, aumentando a demanda por tecnologias avançadas de diagnóstico. Essas soluções permitem a detecção precoce, o tratamento oportuno e melhores resultados em saúde, impulsionando a expansão do mercado e a inovação em soluções de diagnóstico.

Por exemplo,

Em fevereiro de 2025, de acordo com informações publicadas pelo Eurostat, site oficial da União Europeia, em 1º de janeiro de 2024, a população da UE era estimada em 449,3 milhões, com mais de 21,6% com 65 anos ou mais, e uma mediana de idade de 44,7 anos. Esse crescente grupo demográfico de idosos aumenta a demanda por diagnósticos avançados, representando uma oportunidade para o crescimento do mercado.

Com mais de 21% da população do Sul da Europa já com 65 anos ou mais, e com a projeção de que a população idosa da UE quase dobre até 2060, a demanda por diagnósticos avançados tende a aumentar. Como o envelhecimento enfraquece o sistema imunológico, aumentando a suscetibilidade a infecções, o diagnóstico multiplex sindrômico desempenhará um papel vital na detecção precoce e no tratamento oportuno, criando oportunidades de expansão de mercado.

Restrições/Desafios

  • Alto custo dos produtos de diagnóstico

Instituições de saúde menores e ambientes com poucos recursos enfrentam dificuldades para adotar essas tecnologias avançadas devido a restrições financeiras. O diagnóstico multiplex sindrômico também inclui testes multiplex de acesso aleatório totalmente automatizados para ensaios de diagnóstico clínico, proporcionando testes rápidos e precisos. No entanto, todos esses produtos são caros para os usuários finais, o que está dificultando o crescimento do mercado.

Os instrumentos usados ​​no diagnóstico multiplex sindrômico exigem altos custos de manutenção, além de serem muito caros, assim como os reagentes e consumíveis. Por esse motivo, o alto custo dos produtos de diagnóstico está agindo como uma restrição para dificultar o crescimento do mercado europeu de diagnóstico multiplex sindrômico.

  • Desafios na detecção de mecanismos de resistência

Embora os painéis sindrômicos ofereçam identificação rápida e abrangente de patógenos, eles frequentemente falham em detectar mecanismos específicos de resistência antimicrobiana, cruciais para determinar a terapia antibiótica mais apropriada. Essa limitação aumenta o risco de tratamentos inadequados ou ineficazes, potencialmente contribuindo para o crescente problema da resistência antimicrobiana. Infecções causadas por organismos multirresistentes exigem a identificação precisa de marcadores de resistência para garantir intervenções oportunas e direcionadas, mas a incapacidade de alguns testes sindrômicos de fornecer essas informações dificulta a tomada de decisões clínicas. Os profissionais de saúde ainda podem precisar recorrer a métodos de teste convencionais adicionais, aumentando o tempo e os custos do diagnóstico, o que reduz a eficiência geral dos testes sindrômicos. À medida que órgãos reguladores e instituições de saúde enfatizam a importância dos programas de administração antimicrobiana, a necessidade de soluções aprimoradas de diagnóstico sindrômico que detectem efetivamente os mecanismos de resistência torna-se mais premente. A incapacidade de abordar completamente essa questão limita a adoção de painéis sindrômicos e retarda o crescimento do mercado europeu de diagnóstico multiplex sindrômico.

Por exemplo,

Em fevereiro de 2023, de acordo com um artigo do NCBI, os testes genotípicos tiveram dificuldades para detectar mecanismos de resistência não enzimáticos, como perda de porina ou regulação positiva da bomba de efluxo, e apenas previram resistência, não suscetibilidade. Seu alto custo e validação clínica limitada levantam preocupações quanto à sua utilidade, especialmente para bactérias Gram-negativas. Essas limitações representam um desafio significativo para o mercado, restringindo sua eficácia na orientação de terapias antimicrobianas precisas.

Este relatório de mercado fornece detalhes sobre novos desenvolvimentos recentes, regulamentações comerciais, análise de importação e exportação, análise de produção, otimização da cadeia de valor, participação de mercado, impacto de participantes do mercado doméstico e local, análise de oportunidades em termos de bolsões de receita emergentes, mudanças nas regulamentações de mercado, análise estratégica de crescimento de mercado, tamanho de mercado, crescimento de categorias de mercado, nichos de aplicação e dominância, aprovações de produtos, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para obter mais informações sobre o mercado, entre em contato com a Data Bridge Market Research para um Briefing de Analista. Nossa equipe ajudará você a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Escopo de mercado de diagnóstico multiplex sindrômico

O mercado é segmentado em cinco segmentos notáveis ​​com base no tipo de produto, tipo de infecção, doença, usuário final e canal de distribuição. O crescimento entre esses segmentos ajudará você a analisar os segmentos de crescimento escasso nos setores e fornecerá aos usuários uma visão geral e insights valiosos do mercado para ajudá-los a tomar decisões estratégicas para identificar as principais aplicações de mercado.

Tipo de produto

  • Acessórios e Consumíveis
    • Painéis
      • Painéis Respiratórios Multiplex
        • Painéis respiratórios inferiores multiplex
          • Painéis Pneumonia (PN)/Pneumonia Plus (PNPLUS)
          • Teste Unyvero LRT
          • Outro
        • Painéis Respiratórios Superiores Multiplex
          • Painel Viral Respiratório
          • Painel de Patógenos Respiratórios (RPP)/Painel Respiratório 2 (RP2)
          • Painel respiratório EZ (Clia-Waived)
          • Teste Flex de Patógenos Respiratórios (RP Flex)
          • Outros Painéis
        • Painéis GI Multiplex
          • Painel de Patógenos Gastrointestinais (GPP)
          • Painel bacteriano entérico
          • Painel Viral Entérico
          • Painel de Parasitas Entéricos
          • Painel bacteriano entérico estendido
          • Outros Painéis
        • Painéis de hemocultura multiplex
          • Painel BCID (Identificação de Patógenos de Amplo Espectro)
          • Painel BCID-GP (Painel de Bactérias Gram-Positivas)
          • Painel BCID-GN (Painel de Bactérias Gram-Negativas)
          • Painel BCID-FP (Detecção de Patógenos Fúngicos)
          • Teste de hemocultura Gram-Positiva (BC-GP)
          • Teste de hemocultura (BC-GN)
          • Painel de Candida
          • Painel de Bactérias
          • Fenotest BC
          • Outros Painéis
      • Painel Sindrômico de Meningite/Encefalite
      • Painéis de teste STI
      • Outros painéis de diagnóstico multiplex sindrômico
    • Outros
  • Instrumentos
  • Software e Serviços

Tipo de infecção

  • Viral
    • Rinovírus
    • Coronavírus
    • Rotavírus
    • Adenovírus
    • Outros
  • Bacteriana
    • Estafilococo
    • Pneumoniae
    • Bordetella Pertussis
    • Outros
  • Fúngico
  • Parasitas
  • Outros

Doença

  • Infecções respiratórias
  • Gastroenterite
  • Infecções Sexualmente Transmissíveis
  • Meningite
  • Infecções infantis
  • Imunossupressão
  • Febre Tropical
  • Hepatite
  • Infecções oculares
  • Outras doenças

Usuário final

  • Hospitais
    • Por tipo
      • Público
      • Privado
    • Por nível
      • Nível 1
      • Nível 2
      • Nível 3
  • Laboratórios Clínicos
    • Privado
    • Público
  • Consultórios médicos
  • Empresas Farmacêuticas e de Biotecnologia
  • Institutos de Pesquisa
  • Outros

Canal de Distribuição

  • Licitação Direta
  • Vendas no varejo
    • On-line
    • Off-line
  • Outros

Mercado de Diagnóstico Multiplex Sindrômico

Análise regional do mercado de diagnóstico multiplex sindrômico

O mercado é analisado e insights sobre o tamanho do mercado e tendências são fornecidos por tipo de produto, tipo de infecção, doença, usuário final e canal de distribuição, conforme referenciado acima.

A Alemanha deverá liderar e crescer rapidamente no mercado devido à crescente demanda por resultados diagnósticos rápidos e precisos e às iniciativas estratégicas tomadas pelos participantes do mercado.

A seção sobre países do relatório também apresenta fatores individuais que impactam o mercado e mudanças na regulamentação do mercado doméstico, que impactam as tendências atuais e futuras do mercado. Pontos de dados como análise da cadeia de valor a montante e a jusante, tendências técnicas, análise das cinco forças de Porter e estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para cada país. Além disso, a presença e a disponibilidade de marcas europeias e seus desafios enfrentados devido à concorrência forte ou escassa de marcas locais e nacionais, o impacto de tarifas domésticas e rotas comerciais são considerados na análise de previsão dos dados do país.

Participação no mercado de diagnóstico multiplex sindrômico

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluem visão geral da empresa, finanças da empresa, receita gerada, potencial de mercado, investimento em pesquisa e desenvolvimento, novas iniciativas de mercado, presença na Europa, locais e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produto, abrangência e amplitude do produto e domínio da aplicação. Os dados fornecidos acima referem-se apenas ao foco das empresas em relação ao mercado.

Os líderes de mercado em diagnóstico multiplex sindrômico que operam no mercado são:

  • F. Hoffmann-La Roche Ltd (Suíça)
  • DiaSorin SpA (Itália)
  • BIOMÉRIEUX (França)
  • Thermo Fisher Scientific Inc. (EUA)
  • QIAGEN (Holanda)
  • BD Veritor (BD) (EUA)
  • Bio-Rad Laboratories, Inc. (EUA)
  • Danaher Corporation (EUA)
  • Seegene Inc. (Coreia do Sul)
  • Hologic, Inc. (EUA)
  • Bosch Healthcare Solutions GmbH (Alemanha)
  • Abbott (EUA)
  • QuidelOrtho Corporation (EUA)
  • Biocartis (Bélgica)
  • PathoFinder (Holanda)

Últimos desenvolvimentos no mercado de diagnóstico multiplex sindrômico

  • Em novembro de 2024, a Roche firmou um acordo para adquirir a Poseida Therapeutics por aproximadamente US$ 1 bilhão. Esta aquisição amplia as capacidades da Roche em terapias celulares alogênicas, particularmente para oncologia, imunologia e neurologia. O objetivo é acelerar o desenvolvimento de terapias CAR-T prontas para uso, beneficiando os pacientes ao aumentar o acesso ao tratamento e melhorar os resultados clínicos. A transação deverá ser concluída no primeiro trimestre de 2025.
  • Em setembro de 2024, a Roche lançou o primeiro teste a utilizar sua inovadora tecnologia TAGS para detecção simultânea e de alto rendimento de 12 vírus respiratórios. A nova tecnologia TAGS (Geração de Sinal Ativada por Temperatura) permitiu a detecção simultânea de até 15 alvos em uma única amostra de paciente nos analisadores de diagnóstico molecular de alto rendimento Cobas 5800, 6800 e 8800.
  • Em março de 2023, a Roche anunciou que o Comitê Consultivo de Medicamentos Oncológicos da FDA dos EUA votou a favor do Polivy em combinação com R-CHP para linfoma difuso de grandes células B (LDGCB) não tratado previamente. Essa combinação demonstrou uma melhora significativa na sobrevida livre de progressão em comparação ao regime padrão R-CHOP, oferecendo uma opção promissora de tratamento de primeira linha para pacientes com LDGCB. Espera-se que a decisão melhore os desfechos para pacientes com esse câncer agressivo, cujo progresso no tratamento tem sido limitado nos últimos 20 anos.
  • Em março de 2022, o Luminex da MDiaSorin recebeu a marcação CE para seu Painel de Patógenos Gastrointestinais (GPP) xMAP NxTAG, um teste multiplex que detecta 16 patógenos bacterianos, virais e parasitários em amostras de fezes. Projetado para o Sistema MAGPIX, ele fornece resultados no mesmo dia, aprimorando o diagnóstico rápido, a administração de antibióticos e os testes de alto rendimento para laboratórios clínicos em toda a Europa.
  • Em maio de 2023, a DiaSorin SpA fortalece sua parceria com a MeMed ao assinar um acordo de distribuição para o teste MeMed BV na Itália. Este teste, integrado à IA, diferencia infecções bacterianas de virais, auxiliando na tomada de decisões sobre antibióticos. Validado globalmente, ele aprimora o gerenciamento de pacientes e apoia os esforços para combater a resistência antimicrobiana.

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 INDUSTRY INSIGHTS

4.4 TECHNOLOGY ROADMAP

5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES

6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES

6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS

6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS

 

6.2 RESTRAINTS

6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS

6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS

6.3 OPPORTUNITIES

6.3.1 ADVANCEMENTS IN AI & AUTOMATION

6.3.2 RISING AGING POPULATION IN EUROPE

6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS

6.4 CHALLENGES

6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS

6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE

7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 ACCESSORIES & CONSUMABLES

7.2.1 PANELS

7.2.1.1 MULTIPLEX RESPIRATORY PANELS

7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS

7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS

7.2.1.1.3 UNYVERO LRT TEST

7.2.1.1.4 OTHER

7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS

7.2.1.2.1 RESPIRATORY VIRAL PANEL

7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2)

7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED)

7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX)

7.2.1.2.5 OTHER PANELS

7.2.1.3 MULTIPLEX GI PANELS

7.2.1.3.1 GI PATHOGEN PANEL (GPP)

7.2.1.3.2 ENTERIC BACTERIAL PANEL

7.2.1.3.3 ENTERIC VIRAL PANEL

7.2.1.3.4 ENTERIC PARASITE PANEL

7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL

7.2.1.3.6 OTHER PANELS

7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS

7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION)

7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL)

7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL)

7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION)

7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP)

7.2.1.4.6 BLOOD CULTURE TEST (BC-GN)

7.2.1.4.7 CANDIDA PANEL

7.2.1.4.8 BACTERIA PANEL

7.2.1.4.9 PHENOTEST BC

7.2.1.4.10 OTHER PANELS

7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL

7.2.1.6 STI TEST PANELS

7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS

7.3 INSTRUMENTS

7.4 SOFTWARE & SERVICES

8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

8.1 OVERVIEW

8.2 VIRAL

8.2.1 RHINOVIRUS

8.2.2 CORONAVIRUS

8.2.3 ROTAVIRUS

8.2.4 ADENOVIRUS

8.2.5 OTHERS

8.3 BACTERIAL

8.3.1 STAPHYLOCOCCUS

8.3.2 PNEUMONIA

8.3.3 BORDETELLA PERTUSSIS

8.3.4 OTHERS

8.4 FUNGAL

8.5 PARASITES

8.6 OTHERS

9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

9.1 OVERVIEW

9.2 RESPIRATORY INFECTIONS

9.3 GASTROENTERITIS

9.4 SEXUALLY TRANSMITTED INFECTIONS

9.5 MENINGITIS

9.6 CHILDHOOD INFECTIONS

9.7 IMMUNOSUPPRESSION

9.8 TROPICAL FEVER

9.9 HEPATITIS

9.1 EYE INFECTIONS

9.11 OTHER DISEASES

10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 BY TYPE,

10.2.1.1 PRIVATE

10.2.1.2 PUBLIC

10.2.2 BY LEVEL

10.2.2.1 TIER 1

10.2.2.2 TIER 2

10.2.2.3 TIER 3

10.3 CLINICAL LABORATORIES

10.3.1 BY TYPE

10.3.1.1 PRIVATE

10.3.1.2 PUBLIC

10.4 PHYSICIAN OFFICES

10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.6 RESEARCH INSTITUTES

10.7 OTHERS

11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.3.1 ONLINE

11.3.2 OFFLINE

11.4 OTHERS

12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES

12.1 EUROPE

12.1.1 GERMANY

12.1.2 U.K.

12.1.3 FRANCE

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 NETHERLANDS

12.1.8 TURKEY

12.1.9 BELGIUM

12.1.10 SWEDEN

12.1.11 POLAND

12.1.12 DENMARK

12.1.13 NORWAY

12.1.14 FINLAND

12.1.15 REST OF EUROPE

13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 F. HOFFMANN-LA ROCHE LTD

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENTS

15.2 DIASORIN S.P.A

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 SOULUTION PORTFOLIO

15.2.4 RECENT DEVELOPMENT

15.3 BIOMERIEUX

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS/NEWS

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 QIAGEN

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

 

15.6 ABBOTT

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS/NEWS

15.7 BD VERITOR (BD)

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 BIOCARTIS

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIO-RAD LABORATORIES, INC.

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.1 BOSCH HEALTHCARE SOLUTIONS GMBH

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 DANAHER CORPORATION

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 HOLOGIC, INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENTS/NEWS

15.13 PATHOFINDER

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

 

15.14 QUIDELORTHO CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENTS/NEWS

15.15 SEEGENE INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

Lista de Tabela

TABLE 1 COST OF MULTIPLEX DIAGNOSTIC PRODUCT IN USD

TABLE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 3 EUROPE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 4 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 6 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 7 EUROPE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 10 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 11 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 13 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 14 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 15 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 16 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 17 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 19 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 26 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 27 EUROPE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 31 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 GERMANY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 34 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 35 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 36 GERMANY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 38 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 39 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 40 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 42 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 43 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 45 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 46 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 48 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 49 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 GERMANY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 GERMANY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 52 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 53 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 54 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 56 GERMANY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 58 GERMANY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 59 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 U.K. ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 63 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 64 U.K. MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 67 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 68 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 70 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 71 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 73 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 74 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 77 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 U.K. VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 79 U.K. BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 80 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 81 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 82 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 84 U.K. CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 86 U.K. RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 FRANCE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 91 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 92 FRANCE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 94 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 95 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 96 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 98 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 99 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 101 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 102 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 104 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 105 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 FRANCE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 107 FRANCE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 109 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 110 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 112 FRANCE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 114 FRANCE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 116 ITALY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 120 ITALY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 122 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 123 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 124 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 127 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 129 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 130 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 132 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 133 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 ITALY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 ITALY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 136 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 137 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 138 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 139 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 140 ITALY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 142 ITALY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 143 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 144 SPAIN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 147 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 148 SPAIN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 150 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 151 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 152 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 154 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 155 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 156 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 157 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 158 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 159 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 160 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 161 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 SPAIN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 SPAIN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 164 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 165 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 166 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 168 SPAIN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 170 SPAIN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 171 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 172 RUSSIA ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 175 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 176 RUSSIA MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 178 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 179 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 180 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 182 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 183 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 185 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 186 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 188 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 189 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 RUSSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 191 RUSSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 192 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 193 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 194 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 195 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 196 RUSSIA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 198 RUSSIA RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 200 NETHERLANDS ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 201 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 203 NETHERLANDS MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 204 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 205 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 206 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 207 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 209 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 211 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 212 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 213 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 214 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 215 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 NETHERLANDS VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 217 NETHERLANDS BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 219 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 220 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 222 NETHERLANDS CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 224 NETHERLANDS RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 SWITZERLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 228 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 229 SWITZERLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 230 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 231 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 232 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 233 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 234 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 235 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 236 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 237 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 238 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 239 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 240 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 241 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 242 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 243 SWITZERLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 SWITZERLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 246 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 247 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 249 SWITZERLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 250 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 251 SWITZERLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 252 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 253 TURKEY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 255 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 256 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 257 TURKEY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 258 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 259 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 260 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 261 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 262 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 263 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 264 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 266 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 267 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 269 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 270 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 TURKEY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 TURKEY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 273 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 274 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 275 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 276 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 277 TURKEY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 279 TURKEY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 280 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 BELGIUM ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 282 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 283 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 284 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 285 BELGIUM MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 286 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 288 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 289 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 291 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 292 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 293 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 294 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 295 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 296 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 297 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 298 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 299 BELGIUM VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 BELGIUM BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 302 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 303 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 305 BELGIUM CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 306 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 307 BELGIUM RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 309 SWEDEN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 310 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 313 SWEDEN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 315 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 316 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 317 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 318 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 319 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 320 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 322 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 323 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 325 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 326 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 SWEDEN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 SWEDEN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 329 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 330 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 331 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 333 SWEDEN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 334 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 335 SWEDEN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 337 POLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 338 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 341 POLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 343 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 344 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 345 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 346 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 347 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 348 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 349 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 350 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 351 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 352 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 353 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 354 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 355 POLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 POLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 358 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 359 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 361 POLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 362 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 363 POLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 364 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 365 DENMARK ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 367 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 368 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 369 DENMARK MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 370 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 371 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 372 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 373 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 374 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 375 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 376 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 377 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 378 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 379 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 380 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 381 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 382 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 383 DENMARK VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 384 DENMARK BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 386 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 387 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 389 DENMARK CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 390 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 391 DENMARK RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 NORWAY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 394 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 396 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 397 NORWAY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 398 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 401 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 403 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 404 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 406 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 407 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 409 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 410 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 411 NORWAY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 NORWAY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 413 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 414 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 415 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 417 NORWAY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 418 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 419 NORWAY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 FINLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 422 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 423 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 424 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 425 FINLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 426 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 428 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 429 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 431 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 432 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 434 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 435 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 436 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 437 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 438 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 439 FINLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 440 FINLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 442 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 443 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 444 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 445 FINLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 446 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 447 FINLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 REST OF EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

Lista de Figura

FIGURE 1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS

FIGURE 4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COUNTRY-WISE MARKET ANALYSIS

FIGURE 5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS.

FIGURE 7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE (2024)

FIGURE 12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING PREVALENCE OF INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 15 ACCESSORIES & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 TOTAL NUMBER OF CASES OF TUBERCULOSIS IN 2022 AND 2023

FIGURE 18 TOTAL NUMBER OF CASES OF SEXUALLY TRANSMITTED INFECTIONS (STIS)

FIGURE 19 INCREASE IN THE SHARE OF THE POPULATION AGED 65 YEARS AND OVER BETWEEN 2014 AND 2024

FIGURE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2024

FIGURE 21 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)

FIGURE 22 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2024

FIGURE 25 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2025 TO 2032 (USD THOUSAND)

FIGURE 26 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2025-2032)

FIGURE 27 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE

FIGURE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2024

FIGURE 29 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2025 TO 2032 (USD THOUSAND)

FIGURE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2025-2032)

FIGURE 31 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE

FIGURE 32 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2024

FIGURE 33 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 34 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2025-2032)

FIGURE 35 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE

FIGURE 36 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 37 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 38 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 39 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 40 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT, 2024

FIGURE 41 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2024 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

O mercado é segmentado com base em Segmentação do mercado de diagnóstico multiplex sindrômico na Europa, por tipo de produto (acessórios e consumíveis, instrumentos e software e serviços), tipo de infecção (viral, bacteriana, fúngica, parasitária e outras), doença (infecções respiratórias, gastroenterite, infecções sexualmente transmissíveis , meningite, infecções infantis, imunossupressão, febre tropical, hepatite, infecções oculares e outras doenças), usuário final (hospitais, laboratórios clínicos, consultórios médicos, empresas farmacêuticas e de biotecnologia, institutos de pesquisa e outros), canal de distribuição (licitação direta, vendas no varejo e outros) - Tendências do setor e previsão até 2032 .
O tamanho do Relatório de Análise de Tamanho, Participação e Tendências do Mercado foi avaliado em USD 1.17 USD Billion no ano de 2024.
O Relatório de Análise de Tamanho, Participação e Tendências do Mercado está projetado para crescer a um CAGR de 8.2% durante o período de previsão de 2025 a 2032.
Os principais players do mercado incluem F. Hoffmann-La Roche Ltd, DiaSorin S.p.A, BIOMÉRIEUX, Thermo Fisher Scientific Inc., QIAGEN, BD Veritor (BD), Bio-Rad Laboratories Inc..

Navegue pelas páginas relacionadas

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future